Aldeyra Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALDX)

CUSIP: 01438T106

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
-108,537
Put/Call ratio
32%
SEC-reported price per share
$3.31
Number of holders
103
Value change
-$329,270
Number of buys
50
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,314,437

Security key

01438T106

Report period

Q2 2024

Institutions

103

Top holders

10

Ownership snapshot

Top reported holders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F Highest disclosed value: $28,101,026 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $28.1M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $28.1M
Knoll Capital Management, LLC $17.9M
VANGUARD GROUP INC $12.65M
BlackRock Finance, Inc. $10.83M
KENNEDY CAPITAL MANAGEMENT LLC $4.31M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$28,101,026
8,593,586 shares
— 31 Mar 2024
Knoll Capital Management, LLC
13F
Company
13F
—
denominator unverified
$17,904,937
5,475,516 shares
— 31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$12,651,888
3,869,079 shares
— 31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$10,826,274
3,310,787 shares
— 31 Mar 2024
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$4,310,367
1,318,155 shares
— 31 Mar 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$3,362,598
1,028,198 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
103
Shares
35,332,656
Rows available
103
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
101
Q2 2024 holders
103
Holder diff
2
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .